204 related articles for article (PubMed ID: 9387908)
1. Triple combination antimicrobial regimen in the treatment of infections of neutropenic cancer patients.
Casali A; Santini S; Della Giulia M; Di Lauro L; Vici P; Gionfra T; Sega FM
J Exp Clin Cancer Res; 1997 Sep; 16(3):321-4. PubMed ID: 9387908
[TBL] [Abstract][Full Text] [Related]
2. A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients.
Raad II; Whimbey EE; Rolston KV; Abi-Said D; Hachem RY; Pandya RG; Ghaddar HM; Karl CL; Bodey GP
Cancer; 1996 Apr; 77(7):1386-94. PubMed ID: 8608520
[TBL] [Abstract][Full Text] [Related]
3. [Value of the combination of piperacillin and pefloxacin possibly followed by vancomycin in the treatment of febrile neutropenia in nephrotoxic chemotherapy].
Kattan J; Droz JP; Culine S; Ribrag V; Boutan-Laroze A; Andremont A
Bull Cancer; 1992; 79(7):705-12. PubMed ID: 1467596
[TBL] [Abstract][Full Text] [Related]
4. [Management of 315neutropenic febrile episodes in a cancer center].
Dutronc H; Billhot M; Dupon M; Eghbali H; Donamaria C; Dauchy FA; Reiffers J
Med Mal Infect; 2009 Jun; 39(6):388-93. PubMed ID: 19062208
[TBL] [Abstract][Full Text] [Related]
5. Non-nephrotoxic empiric antimicrobial therapy in febrile neutropenic cancer patients.
Kattan J; Droz JP; Ribrag V; Azab M; Boutan-Laroze A; Andremont A
Eur J Cancer; 1992; 28A(4-5):867-70. PubMed ID: 1524911
[TBL] [Abstract][Full Text] [Related]
6. Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors.
Oguz A; Karadeniz C; Citak EC; Cil V; Eldes N
Pediatr Hematol Oncol; 2006; 23(3):245-53. PubMed ID: 16517540
[TBL] [Abstract][Full Text] [Related]
7. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
Caldwell JW; Singh S; Johnson RH
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():129-34. PubMed ID: 10225583
[TBL] [Abstract][Full Text] [Related]
8. [Value of mono-antibiotic therapy using piperacillin associated with sulbactam and possibly followed by vancomycin in febrile neutropenia in solid tumors].
Abs L; Kattan J; Culine S; Bekradda M; Farhat F; Droz JP
Bull Cancer; 1994 Oct; 81(10):871-6. PubMed ID: 7734770
[TBL] [Abstract][Full Text] [Related]
9. Immediate vs. delayed imipenem treatment in cancer patients with profound neutropenia induced by high-dose chemotherapy: results of a randomized study.
García-Sáenz JA; Martín M; Casado A; Pérez-Segura P; Manrique I; Flores L; Macias JA; Cámara JC; Perezagua C; Díaz-Rubio E
Rev Esp Quimioter; 2002 Sep; 15(3):257-63. PubMed ID: 12582429
[TBL] [Abstract][Full Text] [Related]
10. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
Raad II; Escalante C; Hachem RY; Hanna HA; Husni R; Afif C; Boktour MR; Whimbey EE; Kontoyiannis D; Jacobson K; Kantarjian H; Levett LM; Rolston KV
Cancer; 2003 Sep; 98(5):1039-47. PubMed ID: 12942573
[TBL] [Abstract][Full Text] [Related]
11. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
12. Comparison of norfloxacin and pefloxacin in the prophylaxis of bacterial infection in neutropenic cancer patients.
D'Antonio D; Iacone A; Fioritoni G; Betti S; Dell'Isola M; Quaglietta AM; Accorsi P; Pantalone V; Recchia A; Piergallini A
Drugs Exp Clin Res; 1992; 18(4):141-6. PubMed ID: 1451644
[TBL] [Abstract][Full Text] [Related]
13. Management of the febrile neutropenic patient.
Picazo JJ;
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S120-2; discussion S133-40. PubMed ID: 16243492
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
Jaksic B; Martinelli G; Perez-Oteyza J; Hartman CS; Leonard LB; Tack KJ
Clin Infect Dis; 2006 Mar; 42(5):597-607. PubMed ID: 16447103
[TBL] [Abstract][Full Text] [Related]
15. Management of fever in neutropenic patients with different risks of complications.
Klastersky J
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S32-7. PubMed ID: 15250018
[TBL] [Abstract][Full Text] [Related]
16. NCCN: Fever and neutropenia.
Wade JC; Rubenstein EB;
Cancer Control; 2001; 8(6 Suppl 2):16-21. PubMed ID: 11760554
[No Abstract] [Full Text] [Related]
17. [The infectious complications of bronchial cancer].
Klastersky J
Rev Mal Respir; 1998 Sep; 15(4):451-9. PubMed ID: 9805755
[TBL] [Abstract][Full Text] [Related]
18. [Febrile neutropenia: empiric antibiotic therapy from 1975 to 1997].
Klastersky J
Rev Med Brux; 1997 Oct; 18(5):323-7. PubMed ID: 9441328
[TBL] [Abstract][Full Text] [Related]
19. How should imipenem-cilastatin be used in the treatment of fever and infection in neutropenic cancer patients?
Raad II; Abi-Said D; Rolston KV; Karl CL; Bodey GP
Cancer; 1998 Jun; 82(12):2449-58. PubMed ID: 9635539
[TBL] [Abstract][Full Text] [Related]
20. Imipenem versus targeted therapy in cancer patients.
Aoun M; Crokaert F; Paesmans M; Autier P; Klastersky J
Int J Antimicrob Agents; 1998 Nov; 10(4):263-70. PubMed ID: 9916899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
